This article is strictly the opinion of the author and is to not be considered financial/investment advice. Call to Leap LLC and the author of this article does not claim to be a registered financial advisor (RIA) or financial advisor. Please visit our terms of service and privacy policy before reading this article.
Hi Wealth Builders!
🎄 Gift yourself financial freedom education for the Holidays! 🎄
💸 CLICK HERE to take advantage of our Holiday Sale! 💸
This week, the indexes ended higher. Let's see if the rally will continue into next week to finish the year strong 🙂💪. If you've been with us this entire year, we just want to say thank you for allowing us to be a part of your financial freedom journey. It makes us happy to hear about all of the success our members have had. We continuously strive to provide the best value to our members and we are very excited for what is in store for 2022! 🥳
In the spirit of the holiday season, consider using some of the profit you've made this year to give back to those in need 🙏❤️
Here's a look at the 5-day change for ETF's SPY (or the S&P 500), DIA (or the Dow 30), and QQQ (or the Nasdaq 100).
SPY : 3.54%, closed at $470.6
DIA : 2.85%, closed at $359.36
QQQ : 4.57%, closed at $396.92
Pfizer Inc. 💊
The FDA approved a pill for covid, developed by Pfizer. This will be an interesting thing to see. If we are able to combat covid with more than just vaccinations, we can control it better. Better control over the virus can lead to positive outcomes in the economy.
Student Loans 💵
The Biden administration extends pause on student loan repayments until May 1st 2022. Although they are not being forgiven, this is still great news as this gives more time to people to save more and pay them off quicker.
Rapid Tests 🦠
The Biden administration plans to purchase 500 million at-home tests for covid. With the convenience of being testing in your own home, this limits the spread of infection. This is one of the many ways we can stop the spread of the new variant.
Earnings
Here's earnings for the upcoming week:
Walgreens Boots (WBA): 2022-01-06 Before Market Open (Estimated EPS: 1.31).
Constellation Brands (STZ): 2022-01-06 Before Market Open (Estimated EPS: 2.83).
H&R Block (HRB): 2021-12-27 After Market Close.
Moderna Inc. (MRNA) 💊
MRNA has gotten lots of attention recently due to the pandemic. MRNA is a pharmaceutical and biotechnology company which is one of the companies that developed a vaccine for Covid-19. This company primarily makes money off of the products they develop. It seems as if the only commercial product available for this company right now is the covid-19 vaccine. This company has other vaccines in clinical trials. If successful in clinical trials, they may be made available to the public. If approved, they will be able to have more products available and therefore, more ways to make money. The science community is very strict with clinical trials. If their products are flawed or they don't prove to be efficacious, their products won't be approved. Therefore, pharmaceutical and biotechnology companies are very volatile, as is the case with MRNA. Are MRNA's fundamentals a hard pill to swallow? Let's find out! 🔎
Annual Revenue:
2020-12-31 : $803.4M
2019-12-31 : $60.21M
2018-12-31 : $135.07M
2017-12-31 : $205.83M
2016-12-31 : $108.4M
Earnings History:
2021-11-04 : miss (Estimate: 9.05, Actual: 7.7).
2021-08-05 : beat (Estimate: 5.96, Actual: 6.46).
2021-05-06 : beat (Estimate: 2.39, Actual: 2.84).
2021-02-25 : miss (Estimate: -0.35, Actual: -0.69).
Historical Stock Price Returns:
3-month : -44.2%
1-year : 108.23%
5-year : Not available
Moderna Inc. (MRNA) Max Chart (Yahoo Finance)
MRNA's chart looks like it had its biggest increase during 2020 when it developed the vaccine. It has since been very volatile and not consistent. Their annual top-line revenue is all over the place with some good years and some bad years. We also see that MRNA has delivered 2 misses during their last 4 earnings. When we invest in long-term holds, we typically like to see an increasing annual top-line revenue and a consistent, strong upwards trend.
Want to learn how to make monthly passive income, receive higher returns during bull markets and even profit off of stocks that are trending downwards?
Who Competes with MRNA?
A few of MRNA's competitors include Pfizer Inc. (PFE), Amgen Inc. (AMGN) and AstraZeneca PLC (AZN).
Discord Launched!
Just as a PSA, we released our discord channel! Log in and go to the dashboard at www.calltoleap.com/courses and scroll to the bottom of the page for instructions on how to get plugged into the community.
If you're a paid subscriber, remember to check in on positions in the wheel in your dashboard or in the course pages! Until next time!
- Call to Leap Team
Comentários